Luther Medical Products
This article was originally published in The Gray Sheet
Executive Summary
Receives 510(k) clearance to begin marketing the Port L-Cath soft teflon catheter. The soft catheter "enables infusion [of fluids] into the bloodstream via a small implanted cylinder (a port) in the chest." The Tustin, California-based company will sell the catheter as part of several different kits list priced between $7 and $15. Luther expects to launch sales of the Port L-Cath within the next two months following a brief period of controlled test marketing
You may also be interested in...
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.